Price Alert

LianBio (LIAN)

NASDAQ: LIAN · Real-Time Price · USD

0.32

0.00 (0.31%)

At close: Jan 16, 2025, 10:00 PM

LianBio Statistics

Share Statistics

LianBio has 108.06M shares outstanding. The number of shares has increased by 0% in one year.

Shares Outstanding	108.06M
Shares Change (YoY)	0%
Shares Change (QoQ)	0%
Owned by Institutions (%)	n/a
Shares Floating	25.38M
Failed to Deliver (FTD) Shares	384,131
FTD / Avg. Volume	40.02%

Short Selling Information

Short Interest	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Valuation Ratios

The PE ratio is -1.6 and the forward PE ratio is null. LianBio's PEG ratio is 0.02.

PE Ratio	-1.6
Forward PE	n/a
PS Ratio	0
Forward PS	0.1
PB Ratio	0.68
P/FCF Ratio	-1.75
PEG Ratio	0.02

Financial Ratio History

Enterprise Valuation

LianBio has an Enterprise Value (EV) of 102.11M.

EV / Sales	0
EV / EBITDA	-0.82
EV / EBIT	-1.03
EV / FCF	-1.01

Financial Position

The company has a current ratio of 13.24, with a Debt / Equity ratio of 0.02.

Current Ratio	13.24
Quick Ratio	13.24
Debt / Equity	0.02
Debt / EBITDA	-0.03
Debt / FCF	-0.04
Interest Coverage	0

Financial Efficiency

Return on Equity is -42.44% and Return on Invested Capital is -41.65%.

Return on Equity	-42.44%
Return on Assets	-34.47%
Return on Invested Capital	-41.65%
Revenue Per Employee	n/a
Profits Per Employee	$-676.63K
Employee Count	163
Asset Turnover	0
Inventory Turnover	n/a

Taxes

Income Tax	-332.6K
Effective Tax Rate	0.3%

Stock Price Statistics

The stock price has increased by 14.29% in the last 52 weeks. The beta is 0.23, so LianBio's price volatility has been higher than the market average.

Beta	0.23
52-Week Price Change	14.29%
50-Day Moving Average	0.26
200-Day Moving Average	2.41
Relative Strength Index (RSI)	25.18
Average Volume (20 Days)	959,835

Income Statement

Revenue	n/a
Gross Profit	-1M
Operating Income	-125.35M
Net Income	-110.29M
EBITDA	-124.35M
EBIT	n/a
Earnings Per Share (EPS)	-1.02

Full Income Statement

Balance Sheet

The company has 79.22M in cash and 4.34M in debt, giving a net cash position of 74.88M.

Cash & Cash Equivalents	79.22M
Total Debt	4.34M
Net Cash	74.88M
Retained Earnings	-470.52M
Total Assets	262.9M
Working Capital	232.18M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -99.19M and capital expenditures -1.84M, giving a free cash flow of -101.03M.

Operating Cash Flow	-99.19M
Capital Expenditures	-1.84M
Free Cash Flow	-101.03M
FCF Per Share	-0.94

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LIAN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	-62.31%
FCF Yield	-57.08%

Dividend Details

Analyst Forecast

Currently there are no analyst rating for LIAN.

Price Target	n/a
Price Target Difference	n/a
Analyst Consensus	n/a
Analyst Count	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Scores

Altman Z-Score	-2.38
Piotroski F-Score	2